Cardiac Safety of Noncardiac Drugs
Publication year: 2005
: 978-1-59259-884-7
The authors explain the parameters of cardiac safety at all stages of clinical research and drug development, including both the preclinical and pharmacogenomic aspects generally and the clinical methodologies and technical aspects for investigational drugs based on cardiac repolarization, as defined by the duration of the QTc interval. Additional chapters comprehensively review the application of electrocardiology in clinical research
: Biomedical and Life Sciences, clinical research, clinical trial, drug, drug development, electrocardiogram (ECG), electrocardiography, physiology, research, sudden cardiac death
